148 related articles for article (PubMed ID: 8442432)
21. Collagen-derived markers of bone metabolism in osteogenesis imperfecta.
Lund AM; Hansen M; Kollerup G; Juul A; Teisner B; Skovby F
Acta Paediatr; 1998 Nov; 87(11):1131-7. PubMed ID: 9846914
[TBL] [Abstract][Full Text] [Related]
22. Compositional analysis of collagen from patients with diverse forms of osteogenesis imperfecta.
Kirsch E; Krieg T; Nerlich A; Remberger K; Meinecke P; Kunze D; Müller PK
Calcif Tissue Int; 1987 Jul; 41(1):11-7. PubMed ID: 3113698
[TBL] [Abstract][Full Text] [Related]
23. Immunohistochemical localization of interstitial collagens in bone tissue from patients with various forms of osteogenesis imperfecta.
Nerlich AG; Brenner RE; Wiest I; Lehmann H; Yang C; Müller PK; von der Mark K
Am J Med Genet; 1993 Jan; 45(2):258-9. PubMed ID: 8456813
[TBL] [Abstract][Full Text] [Related]
24. Morphometric analysis of type I collagen fibrils in the osteoid of osteogenesis imperfecta.
Sarathchandra P; Pope FM; Ali SY
Calcif Tissue Int; 1999 Nov; 65(5):390-5. PubMed ID: 10541766
[TBL] [Abstract][Full Text] [Related]
25. Ultrastructural studies of bones from patients with osteogenesis imperfecta.
Traub W; Arad T; Vetter U; Weiner S
Matrix Biol; 1994 Aug; 14(4):337-45. PubMed ID: 7827757
[TBL] [Abstract][Full Text] [Related]
26. Enzyme histochemical localisation of alkaline phosphatase activity in osteogenesis imperfecta bone and growth plate: a preliminary study.
Sarathchandra P; Cassella JP; Ali SY
Micron; 2005; 36(7-8):715-20. PubMed ID: 16182549
[TBL] [Abstract][Full Text] [Related]
27. Positive linear growth and bone responses to growth hormone treatment in children with types III and IV osteogenesis imperfecta: high predictive value of the carboxyterminal propeptide of type I procollagen.
Marini JC; Hopkins E; Glorieux FH; Chrousos GP; Reynolds JC; Gundberg CM; Reing CM
J Bone Miner Res; 2003 Feb; 18(2):237-43. PubMed ID: 12568401
[TBL] [Abstract][Full Text] [Related]
28. Increased intra-cortical porosity reduces bone stiffness and strength in pediatric patients with osteogenesis imperfecta.
Vardakastani V; Saletti D; Skalli W; Marry P; Allain JM; Adam C
Bone; 2014 Dec; 69():61-7. PubMed ID: 25238898
[TBL] [Abstract][Full Text] [Related]
29. Osteogenesis imperfecta: clinical, cephalometric, and biochemical investigations of OI types I, III, and IV.
Jensen BL; Lund AM
J Craniofac Genet Dev Biol; 1997; 17(3):121-32. PubMed ID: 9338855
[TBL] [Abstract][Full Text] [Related]
30. Defective association between collagen fibrils and proteoglycans in fragile bone of osteogenesis imperfecta.
Nogami H; Oohira A
Clin Orthop Relat Res; 1988 Jul; (232):284-91. PubMed ID: 3383494
[TBL] [Abstract][Full Text] [Related]
31. The functional muscle-bone unit in patients with osteogenesis imperfecta type I.
Veilleux LN; Pouliot-Laforte A; Lemay M; Cheung MS; Glorieux FH; Rauch F
Bone; 2015 Oct; 79():52-7. PubMed ID: 26004918
[TBL] [Abstract][Full Text] [Related]
32. Unexpected ultrastructral changes in bone osteiod collagens in osteogenesis imperfecta.
Sarathchandra P; Pope FM
Micron; 2005; 36(7-8):696-702. PubMed ID: 16182545
[TBL] [Abstract][Full Text] [Related]
33. Abnormal mineral composition of osteogenesis imperfecta bone as determined by electron probe X-ray microanalysis on conventional and cryosections.
Sarathchandra P; Kayser MV; Ali SY
Calcif Tissue Int; 1999 Jul; 65(1):11-5. PubMed ID: 10369727
[TBL] [Abstract][Full Text] [Related]
34. Total body bone mineral and tartrate-resistant acid phosphatase levels in type I and III osteogenesis imperfecta.
Rico H; Revilla M; Iritia M; Arribas I; Fernando Villa L
Miner Electrolyte Metab; 1991; 17(6):396-8. PubMed ID: 1823391
[TBL] [Abstract][Full Text] [Related]
35. Defective collagen fibril formation and mineralization in osteogenesis imperfecta with congenital joint contractures (Bruck syndrome).
Brenner RE; Vetter U; Stöss H; Müller PK; Teller WM
Eur J Pediatr; 1993 Jun; 152(6):505-8. PubMed ID: 8335019
[TBL] [Abstract][Full Text] [Related]
36. [Biochemical markers of bone turnover. New aspect. Metabolic bone markers in osteogenesis imperfecta].
Tanaka H
Clin Calcium; 2009 Aug; 19(8):1142-7. PubMed ID: 19638698
[TBL] [Abstract][Full Text] [Related]
37. Dominantly inherited osteogenesis imperfecta in man: an examination of collagen biosynthesis.
Lancaster G; Goldman H; Scriver CR; Gold RJ; Wong I
Pediatr Res; 1975 Feb; 9(2):83-8. PubMed ID: 1118195
[TBL] [Abstract][Full Text] [Related]
38. Hydroxylation of collagen type I: evidence that both lysyl and prolyl residues are overhydroxylated in osteogenesis imperfecta.
Lehmann HW; Rimek D; Bodo M; Brenner RE; Vetter U; Wörsdörfer O; Karbowski A; Müller PK
Eur J Clin Invest; 1995 May; 25(5):306-10. PubMed ID: 7628516
[TBL] [Abstract][Full Text] [Related]
39. Long-term extracellular matrix metabolism by cultured human osteogenesis imperfecta osteoblasts.
Fedarko NS; Sponseller PD; Shapiro JR
J Bone Miner Res; 1996 Jun; 11(6):800-5. PubMed ID: 8725177
[TBL] [Abstract][Full Text] [Related]
40. Extracellular matrix formation by osteoblasts from patients with osteogenesis imperfecta.
Fedarko NS; Moerike M; Brenner R; Robey PG; Vetter U
J Bone Miner Res; 1992 Aug; 7(8):921-30. PubMed ID: 1442206
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
